{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:38:52Z","timestamp":1790674732399,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Huntington\u2019s disease (HD) is caused by a CAG trinucleotide repeat expansion in the first exon of the\n                    <jats:italic>huntingtin<\/jats:italic>\n                    (\n                    <jats:italic>HTT<\/jats:italic>\n                    ) gene coding for the huntingtin (HTT) protein. The misfolding and consequential aggregation of CAG-expanded mutant HTT (mHTT) underpin HD pathology. Our interest in the life cycle of HTT led us to consider the development of high-affinity small-molecule binders of HTT oligomerized\/amyloid-containing species that could serve as either cellular and in vivo imaging tools or potential therapeutic agents. We recently reported the development of PET tracers CHDI-180 and CHDI-626 as suitable for imaging mHTT aggregates, and here we present an in-depth pharmacological investigation of their binding characteristics. We have implemented an array of in vitro and ex vivo radiometric binding assays using recombinant HTT, brain homogenate-derived HTT aggregates, and brain sections from mouse HD models and humans post-mortem to investigate binding affinities and selectivity against other pathological proteins from indications such as Alzheimer\u2019s disease and spinocerebellar ataxia 1. Radioligand binding assays and autoradiography studies using brain homogenates and tissue sections from HD mouse models showed that CHDI-180 and CHDI-626 specifically bind mHTT aggregates that accumulate with age and disease progression. Finally, we characterized CHDI-180 and CHDI-626 regarding their off-target selectivity and binding affinity to beta amyloid plaques in brain sections and homogenates from Alzheimer\u2019s disease patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-97334-z","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T06:06:24Z","timestamp":1631167584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates"],"prefix":"10.1038","volume":"11","author":[{"given":"Frank","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Hessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schaertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karola","family":"Berg-Rosseburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Bursow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anass","family":"Chiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ebneth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Gehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hoeschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Hotze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Khetarpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kiselyov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Kottig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Ladewig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Lashuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Letschert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Prime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Scheich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schmiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wityak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mu\u00f1oz-Sanju\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"97334_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024240","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez, M., Licitra, F., Underwood, B. R. & Rubinsztein, D. C. Huntington\u2019s disease: Mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a024240 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"97334_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C. A. & Tabrizi, S. J. Huntington\u2019s disease: From molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83\u201398. https:\/\/doi.org\/10.1016\/s1474-4422(10)70245-3 (2011).","journal-title":"Lancet Neurol."},{"key":"97334_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan, P. & Tabrizi, S. J. Huntington\u2019s disease: A clinical review. Eur. J. Neurol. 25, 24\u201334. https:\/\/doi.org\/10.1111\/ene.13413 (2018).","journal-title":"Eur. J. Neurol."},{"key":"97334_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes, A. et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol. Cell 10, 259\u2013269. https:\/\/doi.org\/10.1016\/s1097-2765(02)00602-0 (2002).","journal-title":"Mol. Cell"},{"key":"97334_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071568","author":"S Koyuncu","year":"2017","unstructured":"Koyuncu, S., Fatima, A., Gutierrez-Garcia, R. & Vilchez, D. Proteostasis of huntingtin in health and disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms18071568 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"97334_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","volume":"1049","author":"C Carmo","year":"2018","unstructured":"Carmo, C., Naia, L., Lopes, C. & Rego, A. C. Mitochondrial dysfunction in Huntington\u2019s disease. Adv. Exp. Med. Biol. 1049, 59\u201383. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_3 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"97334_CR7","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil, J. M. & Rego, A. C. Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur. J. Neurosci. 27, 2803\u20132820. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06310.x (2008).","journal-title":"Eur. J. Neurosci."},{"key":"97334_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","volume":"40","author":"BS Khakh","year":"2017","unstructured":"Khakh, B. S. et al. Unravelling and Exploiting Astrocyte Dysfunction in Huntington\u2019s Disease. Trends Neurosci 40, 422\u2013437. https:\/\/doi.org\/10.1016\/j.tins.2017.05.002 (2017).","journal-title":"Trends Neurosci"},{"key":"97334_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The Biology of Huntingtin. Neuron 89, 910\u2013926. https:\/\/doi.org\/10.1016\/j.neuron.2016.02.003 (2016).","journal-title":"Neuron"},{"key":"97334_CR10","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.drudis.2014.02.006","volume":"19","author":"MD Sepers","year":"2014","unstructured":"Sepers, M. D. & Raymond, L. A. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington\u2019s disease. Drug Discov. Today 19, 990\u2013996. https:\/\/doi.org\/10.1016\/j.drudis.2014.02.006 (2014).","journal-title":"Drug Discov. Today"},{"key":"97334_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/cns.12804","volume":"24","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Wan, J. Q. & Tong, X. P. Potassium channel dysfunction in neurons and astrocytes in Huntington\u2019s disease. CNS Neurosci. Ther. 24, 311\u2013318. https:\/\/doi.org\/10.1111\/cns.12804 (2018).","journal-title":"CNS Neurosci. Ther."},{"key":"97334_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker, L. C. & Jucker, M. Neurodegenerative diseases: Expanding the prion concept. Annu. Rev. Neurosci. 38, 87\u2013103. https:\/\/doi.org\/10.1146\/annurev-neuro-071714-033828 (2015).","journal-title":"Annu. Rev. Neurosci."},{"key":"97334_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrneurol.2014.178","volume":"10","author":"M Pievani","year":"2014","unstructured":"Pievani, M., Filippini, N., van den Heuvel, M. P., Cappa, S. F. & Frisoni, G. B. Brain connectivity in neurodegenerative diseases\u2013from phenotype to proteinopathy. Nat. Rev. Neurol. 10, 620\u2013633. https:\/\/doi.org\/10.1038\/nrneurol.2014.178 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"97334_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/164_2017_60","volume":"245","author":"F Longhena","year":"2018","unstructured":"Longhena, F., Spano, P. & Bellucci, A. Targeting of disordered proteins by small molecules in neurodegenerative diseases. Handb. Exp. Pharmacol. 245, 85\u2013110. https:\/\/doi.org\/10.1007\/164_2017_60 (2018).","journal-title":"Handb. Exp. Pharmacol."},{"key":"97334_CR15","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1083\/jcb.201709172","volume":"216","author":"H Kawamata","year":"2017","unstructured":"Kawamata, H. & Manfredi, G. Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases. J. Cell Biol. 216, 3917\u20133929. https:\/\/doi.org\/10.1083\/jcb.201709172 (2017).","journal-title":"J. Cell Biol."},{"key":"97334_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45\u201351. https:\/\/doi.org\/10.1038\/nature12481 (2013).","journal-title":"Nature"},{"key":"97334_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","author":"BN Dugger","year":"2017","unstructured":"Dugger, B. N. & Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a028035 (2017).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"97334_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/B978-0-444-51892-7.00025-5","volume":"103","author":"SD Donato","year":"2012","unstructured":"Donato, S. D., Mariotti, C. & Taroni, F. Spinocerebellar ataxia type 1. Handb. Clin. Neurol. 103, 399\u2013421. https:\/\/doi.org\/10.1016\/B978-0-444-51892-7.00025-5 (2012).","journal-title":"Handb. Clin. Neurol."},{"key":"97334_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate, M. & Finkbeiner, S. Protein aggregates in Huntington\u2019s disease. Exp. Neurol. 238, 1\u201311. https:\/\/doi.org\/10.1016\/j.expneurol.2011.12.013 (2012).","journal-title":"Exp. Neurol."},{"key":"97334_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2016.11.008","volume":"82","author":"M Banerjee","year":"2017","unstructured":"Banerjee, M., Datta, M. & Bhattacharyya, N. P. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors. Int. J. Biochem. Cell Biol. 82, 1\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2016.11.008 (2017).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"97334_CR21","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/s0140-6736(03)13304-1","volume":"361","author":"G Bates","year":"2003","unstructured":"Bates, G. Huntingtin aggregation and toxicity in Huntington\u2019s disease. Lancet 361, 1642\u20131644. https:\/\/doi.org\/10.1016\/s0140-6736(03)13304-1 (2003).","journal-title":"Lancet"},{"key":"97334_CR22","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005. https:\/\/doi.org\/10.1038\/nrdp.2015.5 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"97334_CR23","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1093\/hmg\/ddx260","volume":"26","author":"J Branco-Santos","year":"2017","unstructured":"Branco-Santos, J. et al. Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity. Hum. Mol. Genet. 26, 3763\u20133775. https:\/\/doi.org\/10.1093\/hmg\/ddx260 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"97334_CR24","doi-asserted-by":"publisher","first-page":"E10809","DOI":"10.1073\/pnas.1705372114","volume":"114","author":"C Cariulo","year":"2017","unstructured":"Cariulo, C. et al. Phosphorylation of huntingtin at residue T3 is decreased in Huntington\u2019s disease and modulates mutant huntingtin protein conformation. Proc. Natl. Acad. Sci. U. S. A. 114, E10809-e10818. https:\/\/doi.org\/10.1073\/pnas.1705372114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"97334_CR25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/acschemneuro.8b00027","volume":"9","author":"F Matthes","year":"2018","unstructured":"Matthes, F. et al. Reducing mutant Huntingtin protein expression in living cells by a newly identified RNA CAG Binder. ACS Chem. Neurosci. 9, 1399\u20131408. https:\/\/doi.org\/10.1021\/acschemneuro.8b00027 (2018).","journal-title":"ACS Chem. Neurosci."},{"issue":"Suppl","key":"97334_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl), S10-17. https:\/\/doi.org\/10.1038\/nm1066 (2004).","journal-title":"Nat. Med."},{"key":"97334_CR27","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.str.2019.08.003","volume":"27","author":"M Tao","year":"2019","unstructured":"Tao, M., Pandey, N. K., Barnes, R., Han, S. & Langen, R. Structure of membrane-bound Huntingtin exon 1 reveals membrane interaction and aggregation mechanisms. Structure 27, 1570-1580.e1574. https:\/\/doi.org\/10.1016\/j.str.2019.08.003 (2019).","journal-title":"Structure"},{"key":"97334_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2017.09.040","volume":"171","author":"RG Yau","year":"2017","unstructured":"Yau, R. G. et al. Assembly and function of heterotypic ubiquitin chains in cell-cycle and protein quality control. Cell 171, 918-933.e920. https:\/\/doi.org\/10.1016\/j.cell.2017.09.040 (2017).","journal-title":"Cell"},{"key":"97334_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/dnnd.S163808","volume":"9","author":"WF Kaemmerer","year":"2019","unstructured":"Kaemmerer, W. F. & Grondin, R. C. The effects of huntingtin-lowering: What do we know so far?. Degener Neurol. Neuromuscul. Dis. 9, 3\u201317. https:\/\/doi.org\/10.2147\/dnnd.S163808 (2019).","journal-title":"Degener Neurol. Neuromuscul. Dis."},{"key":"97334_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/d41573-019-00018-7","volume":"18","author":"A Mullard","year":"2019","unstructured":"Mullard, A. Pioneering antisense drug heads into pivotal trials for Huntington disease. Nat. Rev. Drug Discov. 18, 161\u2013163. https:\/\/doi.org\/10.1038\/d41573-019-00018-7 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"97334_CR31","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting Huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316. https:\/\/doi.org\/10.1056\/NEJMoa1900907 (2019).","journal-title":"N. Engl. J. Med."},{"key":"97334_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/mdc3.12803","volume":"6","author":"A Medina Escobar","year":"2019","unstructured":"Medina Escobar, A., Bruno, V. & Sarna, J. R. Second-generation antisense nucleotide targeting huntingtin expression found to be safe in patients with Huntington\u2019s disease. Mov. Disord. Clin. Pract. 6, 434\u2013435. https:\/\/doi.org\/10.1002\/mdc3.12803 (2019).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"97334_CR33","unstructured":"Wave. Wave Life Sciences Provides Update on Phase 1b\/2a PRECISION-HD Trials. https:\/\/ir.wavelifesciences.com\/node\/9126\/pdf (2021)."},{"key":"97334_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jnnp-2019-322402","volume":"92","author":"TE Cope","year":"2021","unstructured":"Cope, T. E., Weil, R. S., Duzel, E., Dickerson, B. C. & Rowe, J. B. Advances in neuroimaging to support translational medicine in dementia. J. Neurol. Neurosurg. Psychiatry 92, 263\u2013270. https:\/\/doi.org\/10.1136\/jnnp-2019-322402 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"97334_CR35","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","volume":"41","author":"SM Landau","year":"2014","unstructured":"Landau, S. M. et al. Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers. Eur. J. Nucl. Med. Mol. Imag. 41, 1398\u20131407. https:\/\/doi.org\/10.1007\/s00259-014-2753-3 (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"97334_CR36","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.3390\/cells9122581","volume":"9","author":"H Wilson","year":"2020","unstructured":"Wilson, H., Politis, M., Rabiner, E. A. & Middleton, L. T. Novel PET biomarkers to disentangle molecular pathways across age-related neurodegenerative diseases. Cells 9, 2581. https:\/\/doi.org\/10.3390\/cells9122581 (2020).","journal-title":"Cells"},{"key":"97334_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","volume":"27","author":"LK Huang","year":"2020","unstructured":"Huang, L. K., Chao, S. P. & Hu, C. J. Clinical trials of new drugs for Alzheimer disease. J. Biomed. Sci. 27, 18. https:\/\/doi.org\/10.1186\/s12929-019-0609-7 (2020).","journal-title":"J. Biomed. Sci."},{"key":"97334_CR38","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1021\/acs.jmedchem.1c00667","volume":"64","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. [11C]CHDI-626, a PET tracer candidate for imaging mutant Huntingtin aggregates with reduced binding to AD pathological proteins. J. Med. Chem. 64, 12003\u201312021. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00667 (2021).","journal-title":"J Med Chem"},{"key":"97334_CR39","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.jmedchem.0c00955","volume":"63","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Imaging mutant Huntingtin aggregates: Development of a potential PET ligand. J. Med. Chem. 63, 8608\u20138633. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00955 (2020).","journal-title":"J Med Chem"},{"key":"97334_CR40","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/ncomms3753","volume":"4","author":"J Leitman","year":"2013","unstructured":"Leitman, J., Ulrich Hartl, F. & Lederkremer, G. Z. Soluble forms of polyQ-expanded Huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat. Commun. 4, 2753. https:\/\/doi.org\/10.1038\/ncomms3753 (2013).","journal-title":"Nat. Commun."},{"key":"97334_CR41","doi-asserted-by":"publisher","first-page":"12074","DOI":"10.1074\/jbc.M116.713982","volume":"291","author":"S Vieweg","year":"2016","unstructured":"Vieweg, S., Ansaloni, A., Wang, Z. M., Warner, J. B. & Lashuel, H. A. An intein-based strategy for the production of tag-free huntingtin exon 1 proteins enables new insights into the polyglutamine dependence of httex1 aggregation and fibril formation. J. Biol. Chem. 291, 12074\u201312086. https:\/\/doi.org\/10.1074\/jbc.M116.713982 (2016).","journal-title":"J. Biol. Chem."},{"key":"97334_CR42","doi-asserted-by":"publisher","first-page":"Rc189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","volume":"21","author":"ED Agdeppa","year":"2001","unstructured":"Agdeppa, E. D. et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer\u2019s disease. J. Neurosci. 21, Rc189 (2001).","journal-title":"J. Neurosci."},{"key":"97334_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled, L. B. et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7, e49838. https:\/\/doi.org\/10.1371\/journal.pone.0049838 (2012).","journal-title":"PLoS ONE"},{"key":"97334_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213521","volume":"14","author":"W Reindl","year":"2019","unstructured":"Reindl, W. et al. Meso scale discovery-based assays for the detection of aggregated huntingtin. PLoS ONE 14, e0213521. https:\/\/doi.org\/10.1371\/journal.pone.0213521 (2019).","journal-title":"PLoS ONE"},{"issue":"Suppl 4","key":"97334_CR45","doi-asserted-by":"publisher","first-page":"16400","DOI":"10.1073\/pnas.182426599","volume":"99","author":"V Heiser","year":"2002","unstructured":"Heiser, V. et al. Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington\u2019s disease by using an automated filter retardation assay. Proc. Natl. Acad. Sci. U. S. A. 99(Suppl 4), 16400\u201316406. https:\/\/doi.org\/10.1073\/pnas.182426599 (2002).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"97334_CR46","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1073\/pnas.110138997","volume":"97","author":"V Heiser","year":"2000","unstructured":"Heiser, V. et al. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington\u2019s disease therapy. Proc. Natl. Acad. Sci. U. S. A. 97, 6739\u20136744. https:\/\/doi.org\/10.1073\/pnas.110138997 (2000).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"97334_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","volume":"2","author":"JY Li","year":"2005","unstructured":"Li, J. Y., Popovic, N. & Brundin, P. The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies. NeuroRx 2, 447\u2013464. https:\/\/doi.org\/10.1602\/neurorx.2.3.447 (2005).","journal-title":"NeuroRx"},{"key":"97334_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096854","volume":"9","author":"D Macdonald","year":"2014","unstructured":"Macdonald, D. et al. Quantification assays for total and polyglutamine-expanded huntingtin proteins. PLoS ONE 9, e96854. https:\/\/doi.org\/10.1371\/journal.pone.0096854 (2014).","journal-title":"PLoS ONE"},{"key":"97334_CR49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506. https:\/\/doi.org\/10.1016\/s0092-8674(00)81369-0 (1996).","journal-title":"Cell"},{"key":"97334_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/jhd-180329","volume":"7","author":"EL Morozko","year":"2018","unstructured":"Morozko, E. L. et al. Longitudinal biochemical assay analysis of mutant Huntingtin exon 1 protein in R6\/2 mice. J. Huntingtons Dis. 7, 321\u2013335. https:\/\/doi.org\/10.3233\/jhd-180329 (2018).","journal-title":"J. Huntingtons Dis."},{"key":"97334_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155834","volume":"11","author":"Z Bayram-Weston","year":"2016","unstructured":"Bayram-Weston, Z., Jones, L., Dunnett, S. B. & Brooks, S. P. Comparison of mHTT antibodies in Huntington\u2019s disease mouse models reveal specific binding profiles and steady-state ubiquitin levels with disease development. PLoS ONE 11, e0155834. https:\/\/doi.org\/10.1371\/journal.pone.0155834 (2016).","journal-title":"PLoS ONE"},{"key":"97334_CR52","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst, C. A. et al. Nuclear and neuropil aggregates in Huntington\u2019s disease: Relationship to neuropathology. J. Neurosci. 19, 2522\u20132534 (1999).","journal-title":"J. Neurosci."},{"key":"97334_CR53","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk, W. E. et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306\u2013319. https:\/\/doi.org\/10.1002\/ana.20009 (2004).","journal-title":"Ann. Neurol."},{"key":"97334_CR54","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1523\/jneurosci.2990-05.2005","volume":"25","author":"WE Klunk","year":"2005","unstructured":"Klunk, W. E. et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer\u2019s disease brain but not in transgenic mouse brain. J. Neurosci. 25, 10598\u201310606. https:\/\/doi.org\/10.1523\/jneurosci.2990-05.2005 (2005).","journal-title":"J. Neurosci."},{"key":"97334_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe, R. et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Ann. Neurol. 68, 319\u2013329. https:\/\/doi.org\/10.1002\/ana.22068 (2010).","journal-title":"Ann. Neurol."},{"key":"97334_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-7477-1_5","volume":"1709","author":"M van Waarde-Verhagen","year":"2018","unstructured":"van Waarde-Verhagen, M. & Kampinga, H. H. Measurement of chaperone-mediated effects on polyglutamine protein aggregation by the filter trap assay. Methods Mol. Biol. 1709, 59\u201374. https:\/\/doi.org\/10.1007\/978-1-4939-7477-1_5 (2018).","journal-title":"Methods Mol. Biol."},{"key":"97334_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s0076-6879(99)09026-6","volume":"309","author":"EE Wanker","year":"1999","unstructured":"Wanker, E. E. et al. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309, 375\u2013386. https:\/\/doi.org\/10.1016\/s0076-6879(99)09026-6 (1999).","journal-title":"Methods Enzymol."},{"key":"97334_CR58","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1471-4159.2007.05032.x","volume":"104","author":"A Weiss","year":"2008","unstructured":"Weiss, A. et al. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington\u2019s disease. J. Neurochem. 104, 846\u2013858. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05032.x (2008).","journal-title":"J. Neurochem."},{"key":"97334_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549\u2013558. https:\/\/doi.org\/10.1016\/s0092-8674(00)80514-0 (1997).","journal-title":"Cell"},{"key":"97334_CR60","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2007.09.023","volume":"374","author":"G Darnell","year":"2007","unstructured":"Darnell, G., Orgel, J. P., Pahl, R. & Meredith, S. C. Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J. Mol. Biol. 374, 688\u2013704. https:\/\/doi.org\/10.1016\/j.jmb.2007.09.023 (2007).","journal-title":"J. Mol. Biol."},{"key":"97334_CR61","doi-asserted-by":"publisher","first-page":"8820","DOI":"10.1021\/jacs.7b00838","volume":"139","author":"H Kang","year":"2017","unstructured":"Kang, H. et al. Emerging beta-sheet rich conformations in supercompact Huntingtin exon-1 mutant structures. J. Am. Chem. Soc. 139, 8820\u20138827. https:\/\/doi.org\/10.1021\/jacs.7b00838 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"97334_CR62","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4161\/pri.23807","volume":"7","author":"M Kim","year":"2013","unstructured":"Kim, M. Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residues. Prion 7, 221\u2013228. https:\/\/doi.org\/10.4161\/pri.23807 (2013).","journal-title":"Prion"},{"key":"97334_CR63","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1074\/jbc.M117.813667","volume":"293","author":"NK Pandey","year":"2018","unstructured":"Pandey, N. K. et al. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms. J. Biol. Chem. 293, 2597\u20132605. https:\/\/doi.org\/10.1074\/jbc.M117.813667 (2018).","journal-title":"J. Biol. Chem."},{"key":"97334_CR64","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/hmg\/ddi071","volume":"14","author":"MA Poirier","year":"2005","unstructured":"Poirier, M. A., Jiang, H. & Ross, C. A. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: Evidence for a compact beta-sheet structure. Hum. Mol. Genet. 14, 765\u2013774. https:\/\/doi.org\/10.1093\/hmg\/ddi071 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"97334_CR65","doi-asserted-by":"publisher","first-page":"10519","DOI":"10.1002\/jcb.28338","volume":"120","author":"SB Priya","year":"2019","unstructured":"Priya, S. B. & Gromiha, M. M. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths. J. Cell Biochem. 120, 10519\u201310529. https:\/\/doi.org\/10.1002\/jcb.28338 (2019).","journal-title":"J. Cell Biochem."},{"key":"97334_CR66","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1021\/acs.jpcb.8b09213","volume":"122","author":"BG Caulkins","year":"2018","unstructured":"Caulkins, B. G., Cervantes, S. A., Isas, J. M. & Siemer, A. B. Dynamics of the proline-rich C-terminus of Huntingtin exon-1 fibrils. J. Phys. Chem. B 122, 9507\u20139515. https:\/\/doi.org\/10.1021\/acs.jpcb.8b09213 (2018).","journal-title":"J. Phys. Chem. B"},{"key":"97334_CR67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nbd.2018.08.019","volume":"120","author":"KW Drombosky","year":"2018","unstructured":"Drombosky, K. W. et al. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington\u2019s disease. Neurobiol. Dis. 120, 126\u2013138. https:\/\/doi.org\/10.1016\/j.nbd.2018.08.019 (2018).","journal-title":"Neurobiol. Dis."},{"key":"97334_CR68","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2017.09.009","volume":"171","author":"P Guedes-Dias","year":"2017","unstructured":"Guedes-Dias, P. & Holzbaur, E. L. F. Huntingtin fibrils poke membranes. Cell 171, 32\u201333. https:\/\/doi.org\/10.1016\/j.cell.2017.09.009 (2017).","journal-title":"Cell"},{"key":"97334_CR69","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1073\/pnas.1521933113","volume":"113","author":"CL Hoop","year":"2016","unstructured":"Hoop, C. L. et al. Huntingtin exon 1 fibrils feature an interdigitated beta-hairpin-based polyglutamine core. Proc. Natl. Acad. Sci. U. S. A. 113, 1546\u20131551. https:\/\/doi.org\/10.1073\/pnas.1521933113 (2016).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"97334_CR70","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1021\/acs.biochem.7b00138","volume":"56","author":"JM Isas","year":"2017","unstructured":"Isas, J. M., Langen, A., Isas, M. C., Pandey, N. K. & Siemer, A. B. Formation and structure of wild type Huntingtin exon-1 fibrils. Biochemistry 56, 3579\u20133586. https:\/\/doi.org\/10.1021\/acs.biochem.7b00138 (2017).","journal-title":"Biochemistry"},{"key":"97334_CR71","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00401-019-01973-6","volume":"137","author":"M Masnata","year":"2019","unstructured":"Masnata, M. et al. Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. Acta Neuropathol. 137, 981\u20131001. https:\/\/doi.org\/10.1007\/s00401-019-01973-6 (2019).","journal-title":"Acta Neuropathol."},{"key":"97334_CR72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3727\/096368914x678454","volume":"23","author":"HC Fan","year":"2014","unstructured":"Fan, H. C. et al. Polyglutamine (PolyQ) diseases: Genetics to treatments. Cell Transplant. 23, 441\u2013458. https:\/\/doi.org\/10.3727\/096368914x678454 (2014).","journal-title":"Cell Transplant."},{"key":"97334_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether, T., Mariotti, C. & Paulson, H. L. Spinocerebellar ataxia. Nat. Rev. Dis. Primers 5, 24. https:\/\/doi.org\/10.1038\/s41572-019-0074-3 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"97334_CR74","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1590\/0004-282x20180080","volume":"76","author":"CR Martins Junior","year":"2018","unstructured":"Martins Junior, C. R. et al. Twenty-five years since the identification of the first SCA gene: History, clinical features and perspectives for SCA1. Arq Neuropsiquiatr. 76, 555\u2013562. https:\/\/doi.org\/10.1590\/0004-282x20180080 (2018).","journal-title":"Arq Neuropsiquiatr."},{"key":"97334_CR75","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pneurobio.2012.04.003","volume":"99","author":"HT Orr","year":"2012","unstructured":"Orr, H. T. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis. Prog. Neurobiol. 99, 179\u2013185. https:\/\/doi.org\/10.1016\/j.pneurobio.2012.04.003 (2012).","journal-title":"Prog. Neurobiol."},{"key":"97334_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12035-012-8315-4","volume":"46","author":"M Figiel","year":"2012","unstructured":"Figiel, M., Szlachcic, W. J., Switonski, P. M., Gabka, A. & Krzyzosiak, W. J. Mouse models of polyglutamine diseases: Review and data table. Part I. Mol. Neurobiol. 46, 393\u2013429. https:\/\/doi.org\/10.1007\/s12035-012-8315-4 (2012).","journal-title":"Mol. Neurobiol."},{"key":"97334_CR77","doi-asserted-by":"publisher","first-page":"13982","DOI":"10.1021\/ja305470p","volume":"134","author":"V Daebel","year":"2012","unstructured":"Daebel, V. et al. beta-Sheet core of tau paired helical filaments revealed by solid-state NMR. J. Am. Chem. Soc. 134, 13982\u201313989. https:\/\/doi.org\/10.1021\/ja305470p (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"97334_CR78","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4161\/pri.2.3.7488","volume":"2","author":"RN Rambaran","year":"2008","unstructured":"Rambaran, R. N. & Serpell, L. C. Amyloid fibrils: Abnormal protein assembly. Prion 2, 112\u2013117. https:\/\/doi.org\/10.4161\/pri.2.3.7488 (2008).","journal-title":"Prion"},{"key":"97334_CR79","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1073\/pnas.0712290105","volume":"105","author":"C Sachse","year":"2008","unstructured":"Sachse, C., Fandrich, M. & Grigorieff, N. Paired beta-sheet structure of an Abeta(1\u201340) amyloid fibril revealed by electron microscopy. Proc. Natl. Acad. Sci. U. S. A. 105, 7462\u20137466. https:\/\/doi.org\/10.1073\/pnas.0712290105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"97334_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0925-4439(00)00029-6","volume":"1502","author":"LC Serpell","year":"2000","unstructured":"Serpell, L. C. Alzheimer\u2019s amyloid fibrils: Structure and assembly. Biochim. Biophys. Acta 1502, 16\u201330. https:\/\/doi.org\/10.1016\/s0925-4439(00)00029-6 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"97334_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbadis.2004.09.010","volume":"1739","author":"M von Bergen","year":"2005","unstructured":"von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta 1739, 158\u2013166. https:\/\/doi.org\/10.1016\/j.bbadis.2004.09.010 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"97334_CR82","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tibs.2004.08.009","volume":"29","author":"CG Glabe","year":"2004","unstructured":"Glabe, C. G. Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem. Sci. 29, 542\u2013547. https:\/\/doi.org\/10.1016\/j.tibs.2004.08.009 (2004).","journal-title":"Trends Biochem. Sci."},{"key":"97334_CR83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"R Kayed","year":"2007","unstructured":"Kayed, R. et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18\u201318. https:\/\/doi.org\/10.1186\/1750-1326-2-18 (2007).","journal-title":"Mol. Neurodegener."},{"key":"97334_CR84","first-page":"11","volume":"2","author":"\u00d8 Str\u00f8mland","year":"2016","unstructured":"Str\u00f8mland, \u00d8., Jakubec, M., Furse, S. & Halskau, \u00d8. Detection of misfolded protein aggregates from a clinical perspective. J. Clin. Transl. Res. 2, 11\u201326 (2016).","journal-title":"J. Clin. Transl. Res."},{"key":"97334_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 18, e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"PLoS Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97334-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:20:26Z","timestamp":1670062826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97334-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97334"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97334-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"18 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17977"}}